NEW YORK, Dec. 18 (GenomeWeb News) - A unit of General Electric will become Ciphergen Biosystems' post-sale services partner for its ProteinChip systems for hospitals in China, Hong Kong, and Taiwan, the companies said today.
Ciphergen and GE Medical Systems have been working together in Chinaon an "informal basis" for the past year, and have now established a "formal," multi-year services agreement. The agreement is with the Medical Systems' Trade and Development unit.
Financial and other terms of the agreement were not disclosed.
"GE Medical Systems has a major presence ... in China," William Rich, president and CEO of Ciphergen, said in a statement. "Chinais investing heavily in leading edge biotechnology research and we hope to jointly play a significant role in fostering the adoption of our ProteinChip products as research and diagnostic platforms in this important market."